Comparison of pramipexole and citalopram in the treatment of depression in Parkinson's disease: A randomized parallel-group trial

BACKGROUND: Depression is one of the most common neuropsychiatric symptoms in Parkinson's disease (PD). There is little evidence to guide depression treatment in these patients. The aim of this study was to compare citalopram and pramipexole in reducing depressive symptoms in patients with PD....

Descripción completa

Detalles Bibliográficos
Autores principales: Ziaei, Ehsan, Emami Ardestani, Parisa, Chitsaz, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450243/
https://www.ncbi.nlm.nih.gov/pubmed/36092482
http://dx.doi.org/10.4103/jrms.jrms_790_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450243/
https://www.ncbi.nlm.nih.gov/pubmed/36092482
http://dx.doi.org/10.4103/jrms.jrms_790_21

Ejemplares similares